News Category
FingerMotion Inc. reports improved liquidity and reduced cash burn under new management, signaling a strategic shift toward enterprise compute.
Regentis Biomaterials reports progress in its Phase III GelrinC trial for knee cartilage repair and receives European approval for a manufacturing pro...
As more Americans lose health insurance due to rising premiums and recent legislative changes, the financial and health impacts are expected to be fel...
A recent study from the Silver Institute reaffirms the gold-to-silver ratio as a valuable tool for predicting silver price movements, countering claim...
Nanox Imaging Ltd. has signed a distribution agreement with SOLME RC to bring its Nanox.ARC 3D tomosynthesis system to Costa Rica, marking its third L...
Quantum BioPharma's Lucid-MS, a first-in-class drug that protects and rebuilds myelin, has received FDA clearance for a Phase 2 trial that could trans...
TransCode Therapeutics names John Tattory as interim CFO following Tom Fitzgerald's retirement, bringing extensive financial leadership to guide the c...
German sports nutrition brand TNT will attend the ECRM Vitamin, Weight Management & Sports Nutrition Session to build retail partnerships and accelera...
VERAXA Biotech's appointment of Dr. Christoph Erkel as chief scientific officer strengthens its leadership as it advances its BiTAC® T-cell engager an...
Earth Science Tech Inc. reported strong revenue growth and improved financial health for FY2026, demonstrating the success of its vertically integrate...
SS Innovations International (NASDAQ: SSII) has launched Sri Lanka's first robotic cardiac surgery program at Kings Hospital Colombo using its SSi Man...
Quantum BioPharma's FDA clearance for a phase 2 trial of Lucid-MS, a first-in-class myelin-repair therapy, could transform the multibillion-dollar mul...
Quantum BioPharma's Lucid-MS, a first-in-class PAD2 inhibitor, has received FDA clearance to begin a Phase 2 trial for multiple sclerosis, potentially...
Quantum BioPharma's FDA clearance for a phase 2 trial of Lucid-MS represents a historic first in multiple sclerosis treatment, potentially unlocking a...
SS Innovations International reported a 79% increase in procedures using its SSi Mantra surgical robotic system, highlighting its rapid global adoptio...
Helus Pharma's CEO will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference, highlighting the company's advanced clinica...
Onco-Innovations' CMO detailed the company's novel PNKP-targeting drug candidate ONC010, which uses synthetic lethality and nanoparticle delivery to p...
Quantum BioPharma's Lucid-MS, a first-in-class non-covalent PAD2 inhibitor, has received FDA clearance to begin a Phase 2 trial in multiple sclerosis,...
American Fusion Inc. has moved its Texatron fusion program into active testing, achieving peak confinement pressures of approximately 100,000 atmosphe...
American Fusion Inc. has moved its Texatron fusion program into active testing, achieving peak confinement pressures of 100,000 atmospheres, a key ste...
Visory Health's recognition underscores its commitment to fostering innovation through a flat, inclusive culture that directly improves prescription a...
Earth Science Tech's strategic focus on vertical integration and dual-segment targeting has built a self-sustaining business model, positioning the co...
Kairos Pharma's CEO presentation at a major investment conference underscores the company's progress in developing ENV-105, an antibody aimed at rever...
An expert highlights the overlooked shortcomings in UTI diagnosis, emphasizing the need for advanced tools to address recurrent infections and their i...
The World Gold Council's latest insights indicate that gold prices could retreat further due to diminishing momentum, amid conflicting signals from th...
Nutriband's CEO participation at the Nasdaq LaB summit underscores the importance of its AVERSA technology in addressing opioid abuse, potentially inf...
Silo Pharma's participation in the IPAC-RS 2026 Nasal Innovation Forum underscores its commitment to advancing SPC-15, a nose-to-brain therapy for PTS...
Quantum BioPharma's FDA clearance to advance Lucid-MS into Phase 2 trials marks a significant milestone for a novel myelin-repair approach to multiple...
Quantum BioPharma's multiple sclerosis drug candidate Lucid-MS has received FDA clearance to begin a Phase 2 trial, a rare milestone for a micro-cap b...
Helus Pharma's CEO participation in a major investment conference highlights the company's progress in developing novel serotonergic agonists for ment...
The 2026 Disruptive Growth & Life Sciences Conference, organized by Moody Capital Solutions, is set to provide a structured platform for under-covered...
GeoVax applauds the new global mpox vaccine stockpile and highlights its GEO-MVA candidate's readiness to support a diversified supply.
Voyageur Pharmaceuticals has met the first milestone under its Bayer collaboration, receiving USD $1 million to advance a feasibility study for domest...
The August Wellness Index Report highlights the critical role of translational longevity in bringing scientific breakthroughs to patients, featuring e...
Mitch Gould's participation in the ECRM session highlights the ongoing importance of face-to-face relationships in an increasingly digital retail land...
Episode 817 of DH Unplugged dissects Bessent's controversial admission of inside information on the yen, soaring bond yields, and a looming CPI print ...
The Shenzhen-Hong Kong-Guangzhou cluster tops the Global Innovation Index again, highlighting the region's innovation strength and Hong Kong's support...
Greenland Mines is spinning off its biotech division in Q4 2026 to focus on rare earths, following the completion of its Sarfartoq acquisition and a p...
Nano-X Imaging's new distribution agreement with Associated X-Ray Imaging Corp. aims to increase access to its FDA-cleared Nanox.ARC 3D tomosynthesis ...
SS Innovations International is leveraging its established Indian base to expand its SSi Mantra surgical robotic system globally, with strong quarterl...
VERAXA Biotech's appointment of Raju Willener as CFO signals a strategic move to enhance its capital strategy and support the advancement of its oncol...
Scinai Immunotherapeutics has strategically exited its PC111 license with PinCell to concentrate resources on its NanoAb platform and CDMO business, a...
Onco-Innovations Ltd. strengthens its clinical foundation for ONC010, a nanoparticle-encapsulated PNKP inhibitor, through manufacturing milestones, IN...
Wearable Devices will present its AI-powered neural sensing layer at Physical AI 2026, aiming to enhance humanoid robotics with intuitive control.
OS Animal Health's presentation at the Moody Capital conference underscores its strategic push to secure USDA conditional approval for OST-HER2, a pro...
Quantum BioPharma's FDA clearance for a Phase 2 trial of Lucid-MS, a first-in-class myelin repair candidate, marks a pivotal step toward treating the ...
A new study from Washington University School of Medicine highlights the growing role of laser interstitial thermal therapy (LITT) in treating brain c...
Ocumetics Technology Corp. has initiated patient recruitment for the Group Two human clinical study of its next-generation accommodating intraocular l...
